# Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients

> **NCT01447485** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 12 (actual)

## Conditions studied

- Hypertension
- Chronic Kidney Disease
- Nephrotic Syndrome

## Interventions

- **DRUG:** Valsartan (VAL489)

## Key facts

- **NCT ID:** NCT01447485
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447485, "Pharmacokinetics Following Single-dose of Valsartan in Japanese Pediatric Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01447485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*